Ending TB Is Within Reach — So Why Are Millions Still Dying?news2023-11-06T10:00:50+00:00November 6th, 2023|The New York Times|
PEPFAR Turned the Tide of AIDS and It’s Now at Risknews2023-09-21T19:59:01+00:00September 21st, 2023|The New York Times|
Can Africa Get Close to Vaccine Independence? Here’s What It Will Take.news2023-04-25T15:39:50+00:00April 25th, 2023|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
Can New Vaccines Finally Eradicate Malaria?news2022-10-04T10:12:35+00:00October 4th, 2022|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the Worldnews2022-09-12T11:30:34+00:00September 12th, 2022|The New York Times|
In South Africa, Success Against H.I.V. Offers Hopenews2022-01-11T14:59:11+00:00January 11th, 2022|The New York Times|
Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?news2021-12-21T12:27:49+00:00December 21st, 2021|The New York Times|
